Evidence map›Paper›PMID 41323788›Full record

ReviewJournal of Cancer2025

Divulging Patterns: An Analytical Review for Machine Learning Methodologies for Breast Cancer Detection.

Alveena Saleem, Muhammad Umair, Muhammad Tahir Naseem, Muhammad Zubair, Silvia Aparicio Obregon, Ruben Calderon Iglesias, Shoaib Hassan, Imran Ashraf

Abstract readReview
In one paragraph

Review in Journal of Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alveena SaleemFaculty of Information Technology and Computer Science, University of Central Punjab, Lahore, Pakistan.
Muhammad UmairFaculty of Information Technology and Computer Science, University of Central Punjab, Lahore, Pakistan.
Muhammad Tahir NaseemDepartment of Electronic Engineering, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Muhammad ZubairIRC-FDE, King Fahd University of Petroleum and Minerals, 31261, Dhahran, Saudi Arabia.
Silvia Aparicio ObregonUniversidad Europea del Atlantico, Isabel Torres 21, Santander, 39011, Spain.
Ruben Calderon IglesiasUniversidad Europea del Atlantico, Isabel Torres 21, Santander, 39011, Spain.
Shoaib HassanSchool of Computer Science and Engineering, Nanjing University of Science and Technology, Nanjing, 210094, Jiangsu, China.
Imran AshrafDepartment of Information and Communication Engineering, Yeungnam University, Gyeongsan, 38541, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a lethal carcinoma impacting a considerable number of women across the globe. While preventive measures are limited, early detection remains the most effective strategy. Accurate classification of breast tumors into benign and malignant categories is important which may help physicians in diagnosing the disease faster. This survey investigates the emerging inclination and approaches in the area of machine learning (ML) for the diagnosis of breast cancer, pointing out the classification techniques based on both segmentation and feature selection. Certain datasets such as the Wisconsin Diagnostic Breast Cancer Dataset (WDBC), Wisconsin Breast Cancer Dataset Original (WBCD), Wisconsin Prognostic Breast Cancer Dataset (WPBC), BreakHis, and others are being evaluated in this study for the demonstration of their influence on the performance of the diagnostic tools and the accuracy of the models such as Support vector machine, Convolutional Neural Networks (CNNs) and ensemble approaches. The main shortcomings or research gaps such as prejudice of datasets, scarcity of generalizability, and interpretation challenges are highlighted. This research emphasizes the importance of the hybrid methodologies, cross-dataset validation, and the engineering of explainable AI to narrow these gaps and enhance the overall clinical acceptance of ML-based detection tools.

Indexed as

breast cancerdeep learningsegmentationtumor detection

Identifiers

PMID41323788
PMCPMC12664723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.